| Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516) |
|---|
| 08/28/1993 | CA2090772A1 Chelate complexes and processes for their preparation |
| 08/19/1993 | WO1993016097A1 Process of preparing 3-carbonylandrostadiene 17-carboxamides |
| 08/19/1993 | CA2129342A1 Process of preparing 3-carbonylandrostadiene 17-carboxamides |
| 08/18/1993 | EP0555845A2 Steroid derivatives |
| 08/11/1993 | EP0554436A1 Gaba receptor modulators |
| 08/05/1993 | WO1993015103A2 Novel steroid intermediates and processes for their preparation |
| 08/05/1993 | CA2128860A1 Novel steroid intermediates and processes for their preparation |
| 08/03/1993 | US5232917 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 07/22/1993 | WO1993014106A1 Halogenation using halo-vilsmeier reagent |
| 07/22/1993 | CA2127272A1 Halogenation using halo-vilsmeier reagent |
| 07/21/1993 | EP0551953A2 17-(Pyridazine-N-oxide)-substituted steroidal compounds active on the cardiovascular system |
| 07/13/1993 | US5227489 Stable hydrophilic acridinium esters suitable for liposome encapsulation |
| 07/08/1993 | WO1993013123A1 Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids |
| 07/07/1993 | EP0549967A1 Polymers and oligomers of bile-acids, process for their production and their use as medicines |
| 07/07/1993 | EP0549615A1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 06/30/1993 | EP0548798A1 Antiviral agent |
| 06/30/1993 | EP0548793A2 Ethylenic-unsaturated bile acid derivatives, process for their production and preliminary processes therefor |
| 06/30/1993 | CN1021445C Process for preparation of steroids including a spiro ring in position 17 |
| 06/24/1993 | WO1993011772A1 Glycosylated steroid derivatives for transport across biological membranes and process for making same |
| 06/24/1993 | CA2117332A1 Glycosylated steroid acid derivatives for transport across biological membranes and process for making same |
| 06/22/1993 | CA1319362C 4-substituted androstendione derivatives and process for their preparation |
| 06/21/1993 | CA2085830A1 Ethylenically unsaturated bile acid derivatives, processes for their preparation and precursors |
| 05/27/1993 | WO1993010141A2 Angiostatic steroids |
| 05/27/1993 | CA2425846A1 Angiostatic steroids |
| 05/19/1993 | EP0407410B1 Antidiabetic 3-halo-beta-aminoestranes |
| 05/18/1993 | US5212295 Monomers for preparation of oligonucleotides having chiral phosphorus linkages |
| 05/18/1993 | US5212166 Antiandrogens or 5-alpha reductase inhibitors |
| 05/04/1993 | US5208227 Method, compositions, and compounds for modulating brain excitability |
| 04/29/1993 | WO1993007883A1 Derivatized oligonucleotides having improved uptake and other properties |
| 04/28/1993 | EP0538764A1 N-long chain acyl neutral amino acid esters; and cosmetics and pharmaceutical preparation containing the same |
| 04/13/1993 | US5202316 N,N,N',N'-6-(1-piperazinyl)-2,5-pyridinediamines |
| 03/30/1993 | US5198537 Immunogens for immunoassay |
| 03/23/1993 | US5196542 Phospholipase A2 inhibitors |
| 03/23/1993 | US5196411 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors |
| 03/23/1993 | CA1314868C Diamino-androstane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/18/1993 | WO1993005064A1 Steroid sulphatase inhibitors |
| 03/18/1993 | CA2305767A1 Steroid sulphatase inhibitors |
| 03/18/1993 | CA2305758A1 Steroid sulphatase inhibitors |
| 03/18/1993 | CA2305749A1 Steroid sulphatase inhibitors |
| 03/04/1993 | WO1993003732A1 Gaba receptor modulators |
| 03/04/1993 | WO1992018089A3 Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells |
| 02/24/1993 | EP0528485A1 17Beta-acyl-3-androsta-3,5-dienes as testosterone 5alpha-reductase inhibitors |
| 02/24/1993 | EP0527962A1 Method, compositions, and compounds for modulating brain excitability |
| 02/17/1993 | CA2067265A1 17.beta.-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5.alpha.-reductase inhibitors |
| 02/16/1993 | US5187299 Cyclic hydrocarbons with an aminoalkyl sidechain |
| 02/16/1993 | US5187158 Brain-specific drug delivery |
| 12/29/1992 | US5175281 Antiulcer, antiinflammatory, antiischemic, antiallergen, antisecretory, wound healing agents; cardiovascular disorders |
| 12/16/1992 | CN1067057A Process for preparing unsaturated 17 -substituted 3-carboxysteroids |
| 12/09/1992 | EP0517047A1 Unsaturated 17beta-substituted 3-carboxy steroids |
| 12/02/1992 | EP0515386A1 Glycoalkaloids |
| 11/25/1992 | WO1992020700A1 UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS |
| 11/25/1992 | CA2087953A1 Unsaturated 17.beta. -substituted 3-carboxy steroids |
| 11/19/1992 | EP0513177A1 5-oxygenated-2,4,6-triaminopyrimidines |
| 11/18/1992 | CN1066271A 14 beta-h-,14-and 15-ene-11 beta-aryl-4-estrene |
| 10/29/1992 | WO1992018089A2 Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells |
| 10/13/1992 | CA1308707C 20- and 21-amino steroids |
| 10/07/1992 | CN1065070A 6,7-modified 11beta-aryl-4-estrene |
| 09/29/1992 | CA1308095C 11.beta.-ARYLESTRADINENES, THE PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME |
| 09/22/1992 | US5149696 Antiestrogens |
| 09/09/1992 | EP0502112A1 Process for dehydrating corticosteroid intermediates |
| 09/08/1992 | US5145874 Cyclic hydrocarbons with an aminoalkyl sidechain |
| 08/27/1992 | WO1992014474A1 Methods for the treatment of osteoporosis |
| 07/29/1992 | EP0496134A1 Use of 2 beta, 16 beta-diamino-3 alpha, 17-dihydroxy androstane derivatives for the treatment of arrhythmic disorders |
| 07/14/1992 | CA1305131C2 Products useful for the preparation of series 20-keto p regnane products |
| 06/25/1992 | DE4042007A1 6,7-modifizierte-11(beta)-aryl-4-estrene 6,7-modified-11 (beta) -Aryl-4-Estrenes |
| 06/25/1992 | DE4042004A1 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene 14 (beta) -h, 14 u. 15-en-11 (beta) aryl-4-Estrenes |
| 06/23/1992 | WO1992011278A1 14β-H-, 14- AND 15-EN-11β-aryl-4-ESTRENES |
| 06/23/1992 | WO1992011277A1 6,7-MODIFIED 11β-ARYL-4-ESTRENES |
| 06/23/1992 | CA2099018A1 6,7-modified 11.beta.-aryl-4-estrenes |
| 06/23/1992 | CA2099016A1 14.beta.-h-, 14- and 15-en-11.beta.-aryl-4-estrenes |
| 06/22/1992 | CA2058100A1 Use of 2beta,16beta-diamino-3a,17-dihydroxy androstane derivatives |
| 06/10/1992 | EP0489423A1 Bile-acid derivatives, a process for their preparation and their use as medicines |
| 06/09/1992 | US5120723 Alleviate stress, anxiety, seizures |
| 06/02/1992 | CA1302401C Process for the preparation of 21-hydroxy-20-keto-delta__ -steroids and new intermediate compounds formed in this process |
| 05/20/1992 | EP0485392A1 Androgen derivatives for use in the inhibition of sex steroid activity |
| 05/20/1992 | EP0428707A4 Steroid modified oligonucleotides |
| 05/19/1992 | CA1301162C New 11-arylsteroid compounds |
| 05/05/1992 | CA1300020C Method for treating male sexual dysfunction |
| 04/28/1992 | US5108996 Antiinflammatory agents |
| 04/21/1992 | CA1299170C Steroids containing a ketonic radical in positon 23, their preparation process and their use in the preparation of products in the 20-ketopregnane series |
| 04/21/1992 | CA1299169C Steroids having a spiro cycle in position 17, their process and intermediaries,their use as medications and the pharmaceutical preparations containing such |
| 04/08/1992 | EP0203968B1 Method for immunoanalysis of cholesterol epoxides |
| 04/07/1992 | US5103018 Mitomycin derivatives |
| 04/01/1992 | EP0477195A1 Suramin type compounds and angiostatic steroids to inhibit angiogenesis |
| 03/24/1992 | US5099019 Central nervous system steroid derivative drugs |
| 03/19/1992 | WO1990012577A3 Topical anti-angiogenic as hair growth inhibitors |
| 03/10/1992 | US5095130 Novel 23-keto-steroids |
| 03/05/1992 | WO1992003568A1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 02/25/1992 | US5091380 N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors |
| 02/19/1992 | EP0471612A2 New steroids having an amide substituted group in the 11-beta position, their preparation, their use as medicines and pharmaceutical composition thereof |
| 02/15/1992 | CA2049102A1 19-nor-steroids with a carbon chain in 11-beta containing an amido group, preparation thereof, their application as drugs and pharmaceutical compositions containing them |
| 02/11/1992 | US5087618 Antiviral, anticancer, antitumor agents |
| 02/05/1992 | EP0468969A1 Topical anti-angiogenic as hair growth inhibitors |
| 01/14/1992 | US5081113 Novel 3-keto-steroids |
| 01/08/1992 | EP0465155A2 Non-linear optical material containing steroidal ketone compound |
| 01/08/1992 | EP0465141A2 N-monosubstituted adamantyl/norbornanyl 17beta-carbamides of3-carboxy-androst-3,5-dienes |
| 01/08/1992 | EP0465123A2 New intermediates in the synthesis of 17beta-acyl-3-carboxy-androsta-3,5-dienes |
| 12/29/1991 | CA2045867A1 N-monosubstituted adamantyl/norbornanyl 17_beta-carbamides of 3-carboxy-androsts-3,5-dienes as testosterone 5 alpha-reductase inhibitors |
| 12/29/1991 | CA2045865A1 Intermediates on the synthesis of 17 beta-acyl-3-carboxy-androsta-3,5-dienes |
| 12/24/1991 | US5075450 With 2-thiopyridyl substituent |